How to keep the weight off after GLP-1s If you plan to stop taking a GLP-1 medication, you should create a plan to prevent potential weight regain
Dual NOX/SGLT2 inhibitors as the hybrid compound GKT137831 (inhibitor of NOX1 and NOX4) and empagliflozin (SGLT2 inhibitor) have shown synergistic effects, improving insulin sensitivity by 40% in diabetic rodent models ( Emerging strategies focus on mitochondrial-specific antioxidants (e.g., MitoQ, SS-31), which have shown promise in preclinical and early-phase clinical trials by reducing mtROS and improving endothelial function in diabetic patients (Mason et al., 2022)
Possible side effects of Ozempic (semaglutide) injection, Novo Nordisk Ozempic highlights of prescribing information, Novo Nordisk (2023) Comprehensive analysis of the safety of semaglutide in type 2 diabetes: a meta-analysis of the SUSTAIN and PIONEER trials, Endocrine Journal (2021) Understand your risk for excessive blood clotting, American Heart Association (2023) Protective effect of metformin on venous thrombosis in diabetic patients: Findings from a systematic review, Journal of Endocrinology & Metabolism (2022) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
Its short duration, broad-spectrum coverage, and favorable safety profile make it one of the most patient-friendly antibiotic options in modern medicine
Li W, Katzmarzyk P, Horswell R, Wang Y, Johnson J, Hu G
